{"abstract": "The drug maker still needs approval from the United States and Candada for its $68 billion buyout of a rival.", "web_url": "https://dealbook.nytimes.com/2009/09/30/pfizer-gets-ok-from-china-and-australia-for-wyeth-deal/", "snippet": "The drug maker still needs approval from the United States and Candada for its $68 billion buyout of a rival.", "lead_paragraph": "Pfizer, the drug maker, has received regulatory approval from both Chinese and Australian antitrust authorities for its $68 billion buyout of a rival, Wyeth.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer Gets Approval From China and Australia for Wyeth Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-09-30T10:19:22+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/06003243-1426-5c80-82e8-65ad9cc1c818", "word_count": 136, "uri": "nyt://article/06003243-1426-5c80-82e8-65ad9cc1c818"}